Related references
Note: Only part of the references are listed.Targeting natural killer cells in solid tumors
Guillaume Habif et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis
Jing Zhou et al.
IMMUNITY (2019)
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis
Ila Datar et al.
CLINICAL CANCER RESEARCH (2019)
The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector
Wenjuan Dong et al.
CANCER DISCOVERY (2019)
Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming
Aimee Merino et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade
Ziming Wang et al.
NATURE MEDICINE (2019)
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression!
Francesca R. Mariotti et al.
ONCOIMMUNOLOGY (2019)
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
Masao Hashimoto et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Qing Zhang et al.
NATURE IMMUNOLOGY (2018)
Dying cells expose a nuclear antigen cross-reacting with anti-PD-1 monoclonal antibodies
Philipp Metzger et al.
SCIENTIFIC REPORTS (2018)
An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
Nicole A. P. Lieberman et al.
FRONTIERS IN IMMUNOLOGY (2018)
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells
Linda Quatrini et al.
NATURE IMMUNOLOGY (2018)
Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells
Veronika Bachanova et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect
Martin Felices et al.
JCI INSIGHT (2018)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
Y. Liu et al.
ONCOGENE (2017)
Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
Zachary B. Davis et al.
SEMINARS IN IMMUNOLOGY (2017)
Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma
Alexander A. Tong et al.
ONCOIMMUNOLOGY (2017)
Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial
Robert J. Canter et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation
Stefan O. Ciurea et al.
BLOOD (2017)
Analysis of Ly49 gene transcripts in mature NK cells supports a role for the Prol element in gene activation, not gene expression
M. V. McCullen et al.
GENES AND IMMUNITY (2016)
Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway
Yong Yu et al.
NATURE (2016)
PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
Asma Beldi-Ferchiou et al.
ONCOTARGET (2016)
Canine cancer immunotherapy studies: linking mouse and human
Jiwon S. Park et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Natural killer cell memory in infection, inflammation and cancer
Adelheid Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
Acquisition of Activation Receptor Ligand by Trogocytosis Renders NK Cells Hyporesponsive
Cathrine A. Miner et al.
JOURNAL OF IMMUNOLOGY (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Clinical utility of natural killer cells in cancer therapy and transplantation
David A. Knorr et al.
SEMINARS IN IMMUNOLOGY (2014)
PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
Alexander W. MacFarlane et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
Ines Pires da Silva et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Reversal of natural killer cell exhaustion by TIM-3 blockade
Anne Gallois et al.
ONCOIMMUNOLOGY (2014)
PD-1 is a novel regulator of human B-cell activation
Marie-Laure Thibult et al.
INTERNATIONAL IMMUNOLOGY (2013)
T cell regulation of natural killer cells
Yann Kerdiles et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Human NK Cells Selective Targeting of Colon Cancer-Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules
Rossana Tallerico et al.
JOURNAL OF IMMUNOLOGY (2013)
Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells
Franco Locatelli et al.
FRONTIERS IN IMMUNOLOGY (2013)
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Cecele J. Denman et al.
PLOS ONE (2012)
The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells
Emilie Narni-Mancinelli et al.
INTERNATIONAL IMMUNOLOGY (2011)
NK Cell-Depleting Anti-Asialo GM1 Antibody Exhibits a Lethal Off-Target Effect on Basophils In Vivo
Hideto Nishikado et al.
JOURNAL OF IMMUNOLOGY (2011)
Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK Cells
Srinivas S. Somanchi et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M. Benson et al.
BLOOD (2010)
Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
Duck Cho et al.
CLINICAL CANCER RESEARCH (2010)
Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells
Yu Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: How NK cells make the difference
Franco Locatelli et al.
CLINICAL IMMUNOLOGY (2009)
Interferon-sensitive response element (ISRE) is mainly responsible for IFN-α-induced upregulation of programmed death-1 (PD-1) in macrophages
Hae-Yun Cho et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2008)
Differential Regulation of GM1 and Asialo-GM1 Expression by T Cells and Natural Killer (NK) Cells in Respiratory Syncytial Virus Infection
Martin L. Moore et al.
VIRAL IMMUNOLOGY (2008)
Trogocytosis-based generation of suppressive NK cells
Julien Caumartin et al.
EMBO JOURNAL (2007)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Virus-driven evolution of natural killer cell receptors
H Arase et al.
MICROBES AND INFECTION (2002)
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors
H Arase et al.
SCIENCE (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells
MK Slifka et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
